January 21, 2026 – Abbott introduced that it has obtained CE Mark approval in Europe for the TactiFlex™ Duo Ablation Catheter, Sensor Enabled™, for the therapy of sufferers with atrial fibrillation (AFib). Following the brand new approval, the primary profitable business circumstances with TactiFlex Duo within the European Union had been accomplished this week.

Abbott’s TactiFlex Duo catheter is the newest improvement within the firm’s portfolio of pulsed area ablation (PFA) know-how. An efficient cardiac ablation — a minimally invasive process to cease an irregular coronary heart rhythm — depends on the standard of the scars (lesions) created by a catheter to cease the supply of an arrhythmia. TactiFlex Duo is designed to ship personalized remedy lesions in two methods: radiofrequency power (makes use of warmth to destroy tissue chargeable for irregular coronary heart alerts) and pulsed area ablation power (makes use of high-energy electrical pulses to destroy the cells that trigger irregular coronary heart rhythms, which might cut back the danger of injury to adjoining tissue in sufferers with complicated illness or anatomy).

Proceed studying